PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

623 articles indexed across 24 specialties, each reviewed by a licensed pharmacist before publication.

Showing 90 from 1 topic.Sort: Newest | Oldest
Maintenance Capecitabine After mFOLFIRINOX Improves PFS in Metastatic Pancreatic Cancer
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

Capecitabine maintenance boosts survival in metastatic pancreatic cancer.

Busulfan Precision Dosing Evolves From TDM Toward Model-Informed Dosing
Analysis Pharmacokinetics / TDM Confirmatory Grade: Low
Also in Oncology, Pediatrics

Optimizing busulfan dosing in pediatric transplants involves bridging TDM with precision models.

FORTA-Based Pharmacist Review Cuts Medication Problems in Older Cancer Patients
Analysis Ambulatory Care / MTM Confirmatory Grade: Moderate
Also in Oncology, Clinical Practice, Geriatrics

Pharmacist-led reviews reduce inappropriate medication in older cancer patients.

ADCs Reshape Frontline Metastatic Triple-Negative Breast Cancer
Analysis Oncology Pharmacy Confirmatory Grade: Moderate

New therapies offer hope for aggressive TNBC.

Standardized Oral Care Cuts Severe Mucositis in Leukemia Induction
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

Standardized oral care cuts severe mucositis in leukemia chemotherapy by nearly half.

Real-World RCC Data: ICI+TKI Improves PFS, Not Survival
Analysis Oncology Pharmacy Confirmatory Grade: Low

TKI combos may improve initial disease control in metastatic RCC.

Panitumumab in RAS Wild-Type Left-Sided mCRC: Evidence Synthesis
Analysis Oncology Pharmacy Confirmatory Grade: Low

Panitumumab extends survival in metastatic colorectal cancer with precision therapy advances.

Morning neoadjuvant immunotherapy signals better survival in operable NSCLC
Analysis Oncology Pharmacy Hypothesis-generating Grade: Very Low

Infusion timing may enhance survival in NSCLC treatment.

FAERS Signal Links EGFR-TKI Plus Checkpoint Inhibitor to Pneumonitis
★ Editor's Pick Analysis Oncology Pharmacy Hypothesis-generating Grade: Very Low

Increased interstitial pneumonitis risk with combined NSCLC therapy.

Neoadjuvant chemoimmunotherapy plus afatinib yields high pathologic response in head and neck cancer
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

New chemoimmunotherapy regimen shows promise for head and neck cancer.

Pharmacist-Led Deprescribing Halves Inappropriate Medications in Older Cancer Patients
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Low
Also in Oncology

Deprescribing cuts inappropriate medication use in cancer care for older adults.

Cisplatin adds to, does not synergize with, radiation lymphocyte apoptosis
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

Cisplatin adds to radiation's apoptotic impact on cancer patients' lymphocytes.

Chitosan Nanoparticles for Thyroid Cancer: Preclinical Promise, No Clinical Data
Analysis Oncology Pharmacy Hypothesis-generating Grade: Very Low

Chitosan-based nanoparticles could revolutionize thyroid cancer treatment with targeted delivery.

ADCs Reshape Post-Chemoimmunotherapy Options in Esophageal Cancer
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

ADCs offer hope for esophageal cancer after first-line chemoimmunotherapy fails.

Adjuvant Therapy After Neoadjuvant Immunochemotherapy Improves Survival in Resected ESCC
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

Postoperative adjuvant therapy enhances survival for ESCC after neoadjuvant treatment.